Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma have?
Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma has 4,477 citations in the OpenAlex counts ScholarIQ stores.
When was Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma published?
Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma has 2011 year in the ScholarIQ index.
What is the open-access status of Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma?
Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma has green oa status in the ScholarIQ index.
What is the DOI of Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma?
The DOI for Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma is on the source record.
What is the PMID of Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma?
The PMID for Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma is on the source record.
What is the OpenAlex record for Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma?
The OpenAlex for Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma is on the source record.